Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Seelos Announces Dosing of Phase I PK/PD Study of Intranasal Racemic Ketamine

americanpharmaceuticalreviewDecember 30, 2019

Tag: Seelos , Ketamine , SLS-002-102

PharmaSources Customer Service